11.32
Anika Therapeutics Inc Aktie (ANIK) Neueste Nachrichten
Anika Therapeutics focuses on Hyalofast and Cingal advancements for 2025 growth - MSN
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ANIK Stock News - GuruFocus
Anika Therapeutics (ANIK) Sees Target Price Adjustment Amid Futu - GuruFocus
Anika Therapeutics (ANIK) Stock Maintains "Outperform" Rating De - GuruFocus
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Viscosupplementation Market: Executive Briefing & Strategic - openPR.com
Wells Fargo & Company MN Boosts Stock Position in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Investor Network: Anika Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q1 2025 Earnings Call Transcript - Insider Monkey
Anika Therapeutics First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Revenues Working Against Anika Therapeutics, Inc.'s (NASDAQ:ANIK) Share Price - simplywall.st
Anika Therapeutics (ANIK) Faces OEM Challenges Amid Commercial G - GuruFocus
Dimensional Fund Advisors LP Sells 50,011 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Anika Therapeutics Inc (ANIK) Q1 2025 Earnings Call Highlights: Strategic Growth Amidst Revenue ... - Yahoo Finance
Anika Therapeutics Inc (ANIK) Q1 2025 Earnings Call Highlights: Strategic Growth Amidst Revenue Challenges - GuruFocus
Earnings call transcript: Anika Therapeutics Q1 2025 misses forecasts, shares fall - Investing.com Nigeria
Anika Therapeutics Reports Mixed Q1 2025 Results - TipRanks
Anika: Q1 Earnings Snapshot - Norwalk Hour
Anika Therapeutics’ Mixed Earnings Call Reveals Challenges and Growth - TipRanks
Anika Therapeutics Inc Reports Q1 2025 Earnings: EPS of -$0.28 M - GuruFocus
Anika Therapeutics (ANIK) Faces OEM Challenges Amid Commercial Growth - GuruFocus
Anika Therapeutics (ANIK) Reports Revenue Miss, Highlights Strat - GuruFocus
Anika Therapeutics (ANIK) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Anika Therapeutics Inc Reports Q1 2025 Earnings: EPS of -$0.28 Misses Estimate, Revenue of $26.2M Below Expectations - GuruFocus
Anika Therapeutics Posts Wider Loss From Cont. Ops. In Q1 - Nasdaq
Anika (ANIK) Revises 2025 Revenue and Adjusted EBITDA Outlook | ANIK Stock News - GuruFocus
Anika Therapeutics Reports 18% Growth in Commercial Channel Revenue for Q1 2025 Despite Overall Revenue Decline - Nasdaq
Anika Reports First Quarter 2025 Financial Results - GlobeNewswire
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2024 Earnings Call Transcript - MSN
Barclays PLC Buys 2,093 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Earnings To Watch: Anika Therapeutics Inc (ANIK) Reports Q1 2025 Result - GuruFocus
Exploring the Regenerative Medicine (Bone and Joint) Market: - openPR.com
Anika Reports Fourth Quarter and Full Year 2024 Financial Results - ADVFN
Anika to Participate in the Sidoti Virtual Investor Conference - GlobeNewswire
Regenerative Medicine (Bone and Joint) Market Generated - openPR.com
Is The Options Market Predicting A Spike In Anika Therapeutics Stock? - Barchart.com
Is the Options Market Predicting a Spike in Anika Therapeutics Stock? - Nasdaq
Invesco Ltd. Has $452,000 Stock Holdings in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Anika Therapeutics (ANIK) Projected to Post Quarterly Earnings on Friday - Defense World
Envestnet Asset Management Inc. Lowers Position in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Geode Capital Management LLC Has $5.32 Million Stock Holdings in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
JPMorgan Chase & Co. Raises Position in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Anika to Issue First Quarter 2025 Financial Results on Friday, M - GuruFocus
Anika Therapeutics to Announce First Quarter 2025 Financial Results on May 9, 2025 - Nasdaq
Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025 - GlobeNewswire
Anika Earnings Preview: Joint Preservation Giant Reveals Q1 2025 PerformanceKey Metrics to Watch - Stock Titan
Anika Therapeutics (NASDAQ:ANIK) Upgraded at B. Riley - Defense World
B. Riley Initiates Coverage on Anika Therapeutics (NASDAQ:ANIK) - Defense World
B. Riley Initiates Anika Therapeutics at Buy With $21 Price Target - marketscreener.com
Anika Therapeutics (ANIK) Receives 'Buy' Rating with $21 Target from B. Riley Analyst | ANIK Stock News - GuruFocus
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):